Impact of ticagrelor on P2Y1 and P2Y12 localization and on cholesterol levels in platelet plasma membrane
Ticagrelor is an antiplatelet agent that inhibits platelet activation via P2Y12 antagonism. There are several studies showing that P2Y12 needs lipid rafts to be activated, but there are few data about how ticagrelor impacts lipid raft organization. Therefore, we aimed to investigate how ticagrelor c...
Main Authors: | Vahideh Rabani, Damien Montange, Nicolas Meneveau, Siamak Davani |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2018-10-01
|
Series: | Platelets |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/09537104.2017.1356453 |
Similar Items
-
Factors Determining Ticagrelor-Induced Dyspnea in Patients with Acute Coronary Syndrome
by: Vytenis Tamakauskas, et al.
Published: (2022-10-01) -
Pharmacodynamic Comparison of Ticagrelor Monotherapy Versus Ticagrelor and Aspirin in Patients After Percutaneous Coronary Intervention: The TEMPLATE (Ticagrelor Monotherapy and Platelet Reactivity) Randomized Controlled Trial
by: Thomas W. Johnson, et al.
Published: (2020-12-01) -
The Effect of Platelet Activity, ABCB1 Genetic Polymorphism, and Renal Function on the Development of Ticagrelor-Related Dyspnea in Patients with Acute Coronary Syndrome
by: Tamakauskas V, et al.
Published: (2024-01-01) -
Reversal of Platelet Inhibition in Patients Receiving Ticagrelor
by: Piotr Adamski, et al.
Published: (2022-09-01) -
Membrane Environment Modulates Ligand-Binding Propensity of P2Y12 Receptor
by: Fatemeh Haghighi, et al.
Published: (2021-04-01)